No uses medicamentos anlogos del GLP-1 si: eres alrgico a alguno de los principios activos (liraglutida, semaglutida, tirzepatida) o a alguno de los excipientes del medicamento
Even though some individuals with excess adiposity might be relatively metabolically healthy compared to others with a similar BMI, they may still be considered at risk for obesity-related primarily non-metabolic complications (e.g., osteoarthritis, gallstones, gastro-oesophageal reflux disease) 3
Jesse Hsieh says, "What people fail to realize is its not just about weight-loss and cosmetics, but this class of medications called GLP-1s will really introduce an entirely new approach to healthcare in America over the next decade." Dr
The active molecules may be the same
doi: 10.1016/j.rbmo.2010.03.008 119 LafuenteRGonzlez-ComadrnMSolILpezGBrassescoMCarrerasRet al